C1S and Alzheimer disease: The mechanism of action of this SNP remains to be determined through functional experiments; however, given the location of the SNP, it is likely to impact the expression of the protein; indeed, C1s levels have previously been shown to be reduced in the CSF of AD patients, though there is no evidence that this observation is related to the C1S risk SNP [92].